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The human immunodeficiency virus type 1 (HIV-1) envelope (Env) glycoprotein forms trimers that mediate interactions with the CD4 receptor
and a co-receptor on the target cell surface, thereby triggering viral fusion with the cell membrane. Cleavage of Env into its surface, gp120, and
transmembrane, gp41, moieties is necessary for activation of its fusogenicity. Here, we produced pseudoviruses with phenotypically mixed wild-
type (Wt) and mutant, cleavage-incompetent Env in order to quantify the effects of incorporating uncleaved Env on virion infectivity, antigenicity
and neutralization sensitivity. We modeled the relative infectivity of three such phenotypically mixed viral strains, JR-FL, HXBc2 and a derivative
of the latter, 3.2P, as a function of the relative amount of Wt Env. The data were fit very closely (R2 > 0.99) by models which assumed that only Wt
homotrimers were functional, with different approximate thresholds of critical numbers of functional trimers per virion for the three strains. We
also produced 3.2P pseudoviruses containing both a cleavage-competent Env that is defective for binding the neutralizing monoclonal antibody
(NAb) 2G12, and a cleavage-incompetent Env that binds 2G12. The 2G12 NAb was not able to reduce the infectivity of these pseudoviruses
detectably. Their neutralization by the CD4-binding site-directed agents CD4-IgG2 and NAb b12 was also unaffected by 2G12 binding to
uncleaved Env. These results further strengthen the conclusion that only homotrimers consisting of cleaved Env are functional. They also imply
that the function of a trimer is unaffected sterically by the binding of an antibody to an adjacent trimer.
© 2006 Elsevier Inc. All rights reserved.Keywords: HIV-1; Env; Cleavage; Infectivity; Neutralization; Mutants; Dominant-negative; ModelingIntroduction
The human immunodeficiency virus type 1 (HIV-1)
envelope (Env) glycoprotein is synthesized as a precursor
gp160 protein that contains amino-terminal surface glycopro-
tein (gp120) and carboxy-terminal transmembrane glycoprotein
(gp41) components (Land and Braakman, 2001). The nascent
gp160 chains undergo secondary structure formation in the
endoplasmic reticulum (ER) lumen, even before translation is
completed, followed by N-linked glycan addition and disulfide
bond formation (Braakman and van Anken, 2000; Doms et al.,
1993). The folding and processing of gp160 are aided by
molecular chaperones (Earl et al., 1991), which reduce the⁎ Corresponding author. Fax: +1 212 746 8340.
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Ellgaard et al., 1999; Nehls et al., 2000). HIV-1 gp160 is then
oligomerized (Earl et al., 1991) via noncovalent interactions
between the gp41 subunits.
Further along the secretory pathway, gp160 undergoes
cleavage by cellular endoproteases, probably within a post-ER
compartment such as the trans-Golgi network (TGN) or TGN-
derived secretory vesicles (Moulard and Decroly, 2000).
Whereas the HA1 and HA2 proteins of influenza virus, and
varying amounts of the two envelope-protein moieties of some
retroviruses (Hunter and Swanstrom, 1990), are linked by a
disulfide bond, the gp120 and gp41 moieties of the HIV-1 Env
complex remain associated via purely noncovalent interactions
(Colman and Lawrence, 2003; Gallo et al., 2003). Cleavage is
obligatory for the generation of functional Env complexes
(Dubay et al., 1995). Fully replication-competent virions
generally incorporate only cleaved Env proteins (Murakami
122 C. Herrera et al. / Virology 351 (2006) 121–132and Freed, 2000; Trubey et al., 2003). However, under some
experimental conditions, uncleaved gp160 can be incorporated
into virions that are essentially noninfectious (Herrera et al.,
2005). Uncleaved proteins can arise either when cleavage-
competent gp160 is incompletely processed by cellular
proteases, or because the cleavage site has been experimentally
mutated. The introduction of a cleavage-site defect into Env
proteins that are truncated amino-terminally to the transmem-
brane domain also allows the generation of relatively stable,
soluble oligomers (gp140s) for evaluation as vaccine candidates
(Chakrabarti et al., 2002; Srivastava et al., 2002; Yang et al.,
2000, 2002; Zhang et al., 2001). However, there can be
significant antigenic differences between cleaved and uncleaved
oligomeric Env complexes, exemplified by the differential
binding of neutralizing and non-neutralizing monoclonal
antibodies (MAbs) (Herrera et al., 2005; Pancera and Wyatt,
2005; Schulke et al., 2002; Si et al., 2003).
Hetero-oligomers can form, presumably in the ER, when
different Env proteins are co-expressed in the same cell. The
co-expression of mutant forms of Env affects the processing or
function of wild-type (Wt) proteins, a phenomenon that
appears to be a general property of viral Env proteins including
those derived from HIV-1, HIV-2, HTLV-1 and measles virus
(Bour et al., 2003; Chen et al., 1998; Iwatani et al., 2001; Lund
et al., 1998; Plemper et al., 2001; Rosenberg et al., 1999). For
example, hetero-oligomerization could rescue the fusion
function of Env complexes composed of one element incapable
of CD4 binding because of a mutation in gp120, and another
that was rendered fusion-defective by a sequence change in the
gp41 fusion peptide (Salzwedel and Berger, 2000). Presum-
ably, one or two functional gp120 components served to attach
the trimer to CD4, while one or two of the functional gp41
moieties present in the same trimer sufficed to cause membrane
fusion. However, fusion could not be restored when either of
the above Envs formed hetero-oligomers with a cleavage-
defective gp160, suggesting that all three monomers must be
cleaved for the Env complex to function (Salzwedel and
Berger, 2000). Overall, cleavage is one of only a few retroviral
Env functions that apparently mediates a so-called ‘dominant-
negative’ effect: i.e., the co-expression of uncleaved Env
disproportionately interferes with Wt Env function (Iwatani et
al., 2001). Two studies involving the use of phenotypically
mixed pseudoviruses, one focused on neutralization by
antibody (Yang et al., 2005a), the second on the effects of
incorporating defective Env proteins (Yang et al., 2005b), have
concluded that whereas all three Env heterodimers are required
for the trimer to function, only a single functional Env trimer is
required for a virion to infect a cell.
We recently demonstrated that incompletely cleaved and
cleavage-defective forms of Env can be incorporated into
pseudotyped virions, and we examined the effect this has on
their infectivity and neutralization sensitivity (Herrera et al.,
2005). We concluded that the presence of incompletely
processed Wt Env on pseudovirions does not affect neutraliza-
tion of these viruses by Env-specific MAbs. Here, we have
extended these studies to model how the incorporation of
uncleaved Env affects virion infectivity, and to analyze how thebinding of MAbs affects infectivity mediated by Env trimers.
Our experimental data and modeling studies together suggest
that cleavage-defective Env proteins do exert a dominant-
negative effect on function at the trimer level, i.e., all three
gp120-gp41 monomer subunits are required for a trimer to
function; that only antibodies able to bind to functional Env
subunits can neutralize pseudoviruses; and that antibody
binding to one Env trimer does not affect the function of
adjacent, fully functional trimers through a steric mechanism.
Results
Cleavage-defective Env has a dominant-negative inhibitory
effect on infectivity conferred by wild-type Env
It has been reported that the presence of uncleaved HIV-1
Env proteins in an otherwise functional Env oligomer can
impair the fusion function of the entire Env complex, leading to
dominant-negative inhibition of infectivity (Iwatani et al.,
2001). Before assessing the influence of hetero-oligomerization
on the antibody reactivity of Env-pseudotyped viruses, we
sought to confirm and extend these observations. We first co-
transfected 293T cells with varying proportions of plasmids
encoding a Wt Env (one of HXBc2 gp160, JR-FL gp160 or
3.2P(+) gp140Δct; Herrera et al., 2005), and a cleavage-
defective version of the same gp160 or gp140Δct Env. In
addition, the cells were co-transfected with a fixed amount of
packaging/reporter plasmid: pNL4/3.Luc with JR-FL gp160
and HXBc2 gp160; pCMV and pLuc with 3.2P(+) gp140Δct.
When we quantified the infectivity of culture supernatants, we
found that increasing the amount of cleavage-defective Env
impaired, and eventually completely eliminated, the infectivity
conferred by the Wt protein (Fig. 1A). Even when the cleavage-
defective Env protein comprised only 50% of the total Env, this
was sufficient to inhibit infectivity by 74–94% depending on
the strain. A Western blot analysis of lysates from the
transfected 293T cells confirmed that both respective forms of
Env were expressed in proportion to the amount of plasmid in
the transfection (data not shown).
To confirm this finding, we measured the infectivity-to-
particle ratio of iodixanol gradient-purified (Herrera et al.,
2005) 3.2P(+) gp140Δct Env-pseudotyped virions prepared
after co-transfection either with the empty vector or with
cleavage-defective Env in three proportions (Fig. 1B). The
infectivity values (TCID50/ng p24, n = 5) for the 1:1 co-
transfection with empty vector (median: 1.2 × 104; range:
4.9 × 103 to 2.1 × 104) were significantly higher than for the 1:1
co-transfection with cleavage-defective Env (median 1.5 × 103;
range: 2.7 × 102 to 4.5 × 103). Co-expressing the Wt and
cleavage-defective forms of 3.2P gp140Δct Env in a 1:1
proportion caused an ∼10-fold loss of infectivity of sucrose-
pelleted Env-pseudoviruses (Fig. 1C, left panel), but without
altering the amount of p24 that was captured by the anti-gp120
MAb 2G12 (Fig. 1C, right panel). Thus, co-expression of
cleavage-defective Env reduced the infectivity of each Env-
pseudotyped virus particle, rather than simply reducing their
production level.
Fig. 1. Dominant-negative effect of cleavage-defective Env on infectivity conferred by wild-type Env. (A) Phenotypically mixed pseudotyped virions were generated,
containing varying proportions of Wt JR-FL gp160, Wt HXBc2 gp160, 3.2P(+) gp140Δct Env and their cleavage-defective Env counterparts. The infectivity
(luciferase expression in RLU) of the resulting viruses was measured using U87.CD4.CCR5 or U87.CD4.CXCR4 cells, then normalized to the infectivity conferred by
Wt Env (defined as 1.0). The soft-composite-threshold curves fit by nonlinear regression are illustrated for the three viral strains with each data point representing the
mean ± standard error of the number of experimental determinations indicated: JR-FL gp160 (diamonds n = 7), HXBc2 gp160 (squares, n = 4) and 3.2P(+) gp140Δct
(triangles, n = 9) Env-pseudotyped virus. (B) 3.2P(+) gp140Δct Env-pseudotyped virus, expressed in the presence of increasing amounts of empty vector (black bars)
or cleavage-defective 3.2P(−) gp140Δct Env (open bars), was fractionated by iodixanol gradient centrifugation. The infectivity titers (TCID50) of the peak fractions
were normalized relative to their p24 antigen contents. Error bars represent standard deviation. *P = 0.0040 (n = 5; one-tail Mann–Whitney test). (C) 3.2P(+)
gp140Δct Env-pseudotyped viruses were expressed in the absence (Wt; solid bars) or presence of an equal proportion of pseudoviruses bearing a cleavage-defective
Env, either Wt plus 3.2P(−) gp140Δct (1:1; shaded bars) or 3.2P(−) gp140Δct (open bars). The resulting pseudoviruses were clarified by centrifugation through a 20%
sucrose cushion, before addition to wells that either contained absorbed 2G12 or lacked it (control). The p24 content (right panel) and infectivity (left panel) of the
captured pseudoviruses were then measured. Error bars represent standard deviation.
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cleavage-defective Env
To confirm that heterotrimers could, in fact, form under our
experimental conditions, we needed a reliable method to detect
the two forms of Env that constitute the individual components.
Unfortunately, no simple, definitive way to discriminate
between cleavage-defective and Wt Env proteins is sufficiently
robust for this purpose. Instead, we designed a surrogate method
to track the formation of heterotrimers. In this approach, we
assumed that eliminating the 2G12 epitope would have aninconsequential effect on the overall process of trimer
formation. By using 2G12 as an immunoprecipitation reagent,
we attempted to monitor the formation of heterotrimers
containing a 2G12-knockout, but otherwise functional, cleav-
age-competent Env and a cleavage-defective Env with an intact
2G12 epitope.
The 2G12-knockout mutant of 3.2P(+) gp140Δct Env was
created by making alanine substitutions of two amino acids
known to be part of the MAb epitope: N295 and N332 (Scanlan
et al., 2002). As expected, the N295A/N332A double mutant
gp120 protein failed to bind 2G12 in an ELISA but its binding
124 C. Herrera et al. / Virology 351 (2006) 121–132of CD4-IgG2 was almost identical to that of Wt gp120 (Fig.
2A). Similar results were obtained using flow cytometry to
measure 2G12 binding to the N295A/N332A double mutant
Env protein expressed on the surface of 293T cells (data not
shown). Neutralization of the 2G12-knockout 3.2P(+)
gp140Δct Env-pseudotyped virus by the recombinant
CD4-IgG2 molecule was similar to that obtained for the
Wt 3.2P(+) gp140Δct Env-pseudotyped virus, although it
was clearly more resistant to neutralization by MAb 2G12
(Fig. 2B).
We next studied the ability of the cleavage-competent, 2G12-
knockout N295A/N332A 3.2P(+) gp140Δct Env to form
hetero-oligomers with 2G12-reactive, but cleavage-defective
Env. To do this, we used 2G12 to immunoprecipitate detergent-
solubilized trimers from iodixanol-fractionated, Env-pseudo-
typed virions followed by SDS-PAGE resolution of the gp140/
gp41 Env cleavage fragments using MAb 2F5 (Fig. 2C)
(Herrera et al., 2005). When pseudoviruses generated by 1:1 co-
transfection of the above two forms of Env were immunopre-
cipitated (lane 4; gp41 band), the amount of cleaved Env that
was precipitated by 2G12 was greater than the amountsFig. 2. Cleavage-defective Env forms hetero-oligomers with cleavage-competent Env
knockout N295A/N332A 3.2P(+) gp140Δct Env (open symbols) were lysed in 1
determination of CD4-IgG2 (squares) or 2G12 (circles) binding by ELISA. (B) Ne
2G12-knockout N295A/N332A 3.2P(+) gp140Δct Env (open symbols) by CD4-IgG
luciferase readout. Error bars represent standard deviation. (C) AWestern blot using
with 2G12 from iodixanol gradients. The input pseudoviruses contained the followin
2G12-knockout N295A/N332A 3.2P(+) gp140Δct Env; lane 3, cleavage-defective 3.
cleavage-defective Env; lane 5, a 1:1 admixture of 2G12 mutant Env and the cleavag
SDS at 37 °C prior to immunoprecipitation; lane 7, mock sample containing 2G12 and
blot detection MAb, 2F5, are of human origin, the Ig heavy chains are resolved.precipitated when each individual Env species was expressed
alone (lanes 2 and 3). The amount of cleaved Env in the
phenotypically mixed virus (lane 4) that was precipitated was
similar to the amount precipitated when Wt 3.2P(+) gp140Δct
Env was expressed alone (lane 1). Hence, the oligomers
immunoprecipitated by the binding of 2G12 to cleavage-
defective Env must also contain cleavage-competent, 2G12-
knockout Env proteins. In contrast, when equivalent amounts of
the different Env-pseudotyped viruses bearing the cleavage-
competent, 2G12-knockout Env and the cleavage-defective
Env, respectively, were mixed, only the cleavage-defective Env
proteins could be immunoprecipitated by 2G12 (lane 5). We
cannot exclude that separate trimers on the same virion were co-
immunoprecipitated. Thus, although the results do not demon-
strate that heterotrimers were formed, they suggest it: the
detergent sufficiently disrupted the membrane to prevent co-
immunoprecipitation of the Gag protein (data not shown). The
interaction that occurs between the two forms of Env was
noncovalent, because it was disrupted by exposure of the Env-
pseudovirus preparation to 0.025% SDS before immunoprecip-
itation with 2G12 (lane 6).. (A) Pseudovirions expressing 3.2P(+) gp140Δct Env (filled symbols) or 2G12-
% NP40 and captured by immobilized anti-gp120 antibody D7324, prior to
utralization of pseudovirions having 3.2P(+) gp140Δct Env (filled symbols) or
2 (squares) or 2G12 (circles) was assessed using U87.CD4.CXCR4 cells with a
2F5 as the detection antibody was performed on fractions immunoprecipitated
g Envs under the indicated conditions: lane 1, Wt 3.2P(+) gp140Δct Env; lane 2,
2P(−) gp140Δct Env; lane 4, co-transfection of the 2G12-knockout Env and the
e-defective Env; lane 6, the same as lane 4 (1:1 co-transfection) but treated with
protein G agarose beads. As both the precipitating MAb, 2G12, and the Western
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form heterotrimers with Wt Env and cause a consistent, dose-
dependent inhibition of the infectivity of pseudovirions
containing Wt Env, and that the infectivity impairment is not
attributable to a reduction in Env incorporation into the
particles. These results appear to be consistent with uncleaved
Env proteins having a dominant-negative inhibitory effect on
Wt Env function. In order to analyze this effect quantitatively,
we applied mathematical models to predict how trimer
functionality and virus infectivity would vary with the
proportions of Wt and cleavage-defective Env proteins present.
Modeling the effect of uncleaved Env proteins on virion
infectivity
The equations of the models and their derivations are
outlined in Materials and methods and Table 1. Some basic
assumptions are common to all the models. First, we assume
that all cleaved Wt gp120-gp41 heterodimers are potentially
functional while their uncleaved counterparts are inert. We
also presume that mixed trimers form randomly in the endo-
plasmic reticulum between Wt and cleavage-defective mutant
forms of gp120-gp41 heterodimers. We are, of course, aware
that when Wt Env protein is expressed, a fraction (∼30%)
of uncleaved Env can be detected in purified virus (Herrera
et al., 2005). This fraction probably consists predominantly
of uncleaved, nonfunctional homotrimers, rather than mixed
trimers (Herrera et al., 2005). We therefore disregard this
fraction when predicting the impact of expressing cleavage-
defective mutants to increase the proportion of uncleaved Env
proteins.
The key features of the two kinds of model that we compared
and their implications for understanding Env function are as
follows. The first model assumes that all functional trimers on a
virion contribute equally to the infectivity. This obviates theTable 1
Comparison of the proportional–incremental and soft-threshold models of how func
Env
JR-F
Model 1 R2 0.94
Proportionally incremental a a ± SE b 0.36
Model Group 2 R2 0.99
Soft-composite thresholds c b ± SE b 1.77
Degrees of freedom 6
Preferred model Mod
Major peak of threshold (minor) d 6 (9)
AIC score e 16.6
% probability correct f >99.
a The model of proportionally incremental virion infectivity as a function of Env
b The parameters a (constrained to >0, <1) and b (constrained to >0) ± standard e
c The soft threshold models for virions with 9 trimers are given by the equation I = (
(c1 + c2 + c3 + c4 + c5 + c6 + c7 + c8 + c9), where IS=Σr= (9−S+1)
9 9Crq
r(1 − q)9− r and
functional trimers per virion. In the threshold model for HXBc2, c1 = b
2, c
c2 = c3 = c4 = c6 = c7 = c8 = 0, c1 = b
0 c5 = b c9 = b
0; and for JR-FL: c1 = c2 = c3
d Values of S are given, the number of trimers that have to be inactivated for a su
e Akaike's Information Criterion score. The greater the value, the higher the prefe
f The percentage probability that Model Group 2 is correct rather than Model 1 isneed for any assumption about the number of active trimers per
virion. The model then postulates a continuum of possibilities
for the functionality of the individual trimers. One extreme is
that a trimer containing one uncleaved and two cleaved Env
molecules is completely inert, just like trimers with two or three
uncleaved Env molecules: only Wt homotrimers are functional.
Another extreme is that each incorporation of an uncleaved Env
molecule reduces the relative functionality of the trimer by one-
third, a proportionally decremental effect. The model is then fit
to the infectivity data for different mixes of Wt and uncleaved
Env. Avalue of the parameter a close to 1 indicates that only Wt
homotrimers are functional; a = 0 indicates that the functionality
of each trimer is proportional to its content of Wt Env subunits.
As shown in Table 1, good fits could be obtained for all three
viral strains. HXBc2 and 3.2P showed no decremental
component at the trimer level (a ≈ 1), while JR-FL did so
(a = 0.365). In conclusion, this model gives a fair approxima-
tion to the data, but it clashes with the biological principle that
the contribution of the subunits to Env trimer functionality is
likely to be a basic, conserved property common to all HIV-1
strains.
A different and perhaps virologically more realistic model
assumes that a certain proportion of the trimers on each virion is
critical for infectivity (Klasse and Moore, 1996). However, the
threshold for inactivation may be soft or composite because of
several factors, including virion heterogeneity and differences
in how functional trimers are distributed over the virion surface
(Klasse and Moore, 1996). Weights can be allotted to the
thresholds as they are blended into an equation for the average
virion. We assume there are on average 9 trimers per virion (Zhu
et al., 2003), and we let S be the threshold number of trimers that
must be inactivated for the virion to lose its infectivity. Unlike in
Model 1, we furthermore assume that all viral strains are similar
in that trimers with one or more uncleaved Env molecules are
completely inert; only Wt homotrimers are functional. The testtional Env contributes to virion infectivity
L HXBc2 3.2P
0 0.985 0.994
5 ± 0.200 1.00 ± 0.0876 0.935 ± 0.0510
4 1.00 0.997
± 0.336 1.23 ± 0.00715 1.96 ± 0.290
6 6
el Group 2 Model Group 2 Model Group 2
5 (1) 5 (9)
40.0 4.67
9% >99.9% 91.2%
functionality is given by the equation I = ap3 + (1 − a)p.
rror in Model 1 and Model Group 2 were fit by nonlinear regression.
c1IS=1 + c2IS=2 + c3IS=3 + c4IS=4 + c5IS=5 + c6IS= 6 + c7IS=7 + c8IS=8 + c9IS=9) /
coefficients, c1−9, give weights to thresholds of approximate critical numbers of
2 = b
3, c3 = b
4, c4 = b
6, c5 = b
9, c6 = b
6, c7 = c8 = c9 = b
0; for 3.2P:
= c4 = c5 = c7 = c8 = 0, c6 = b, c9 = b
0.
bstantial loss in virion infectivity.
rence of Model Group 2 over Model 1.
calculated based on the AIC score.
Fig. 3. The effect of cleavage-defective Env on the antigenicity of cell surface
Env. 293T cells was co-transfected with plasmids encoding for CMV, Luc and
DsRed2, together with Wt, cleavage-competent 3.2P(+) gp140Δct Env and
increasing levels of cleavage-defective 3.2P(−) gp140Δct Env (solid bars).
Alternatively, the cells were separately transfected with 3.2P(+) gp140Δct Env
and 3.2P(−) gp140Δct Env, then mixed (open bars) as a control. The cells were
labeled with MAb 2G12 or 2F5 at 20 μg/ml. The binding of 2F5 is represented
as a ratio to 2G12 binding. Error bars represent standard deviation. Note that, for
conditions 0 and 1, the bars (±SD) are duplicated for consistency and represent
singly transfected cell populations; i.e., 100% Wt or 100% cleavage-defective
Env, respectively.
126 C. Herrera et al. / Virology 351 (2006) 121–132of this assumption of uniformity is how good are the fits it
yields. In these models, viral strains—or indeed different
preparations of the same strain—are instead allowed to differ at
the virion level in the steepness and composition of theirFig. 4. Neutralization sensitivity of phenotypically mixed Env-pseudotyped viruses
knockout N295A/N332A 3.2P(+) gp140Δct Env (■), 3.2P(+) and 2G12-knockout
3.2P(+) and cleavage-defective 3.2(−) gp140Δct Env co-transfected in a 1:1 proporti
an equal proportion of pseudovirions bearing cleavage-defective 3.2(−) gp140Δct E
with (A) 2G12, (B) CD4-IgG2, (C) b12 or (D) 2F5 at the concentrations indicate
determined after 4 days and the percentage neutralization by each test reagent was cal
from two independent experiments.thresholds of inactivation. We constructed a library of such soft-
composite threshold models. The candidate models that best
approximated the infectivity data for the three viral strains were
then fit by varying a parameter b, which describes the relative
weights of the thresholds. As shown in Table 1, superior fits to
those for Model 1 could be achieved. The threshold for JR-FL
inactivation is composite and high; the threshold for HXBc2 is
lower and peaks smoothly in the middle range; the threshold for
3.2P is composite, a middle peak flanked by a low and a high
peak. Since we do not know the true total number of functional
trimers per virion, which may vary between these strains, and
since the experimental variation is considerable, we want to
emphasize that these models merely illustrate schematic and
approximate properties of these viruses. We conclude, however,
that realistic models that assume a uniform dominant-negative
effect of uncleaved Env at the trimer level, and flexible
thresholds at the virion level, can fit experimental data very
closely. This is illustrated in Fig. 1A, which shows the
parameter-optimized soft-composite-threshold curves for infec-
tivity data derived using JR-FL, HXBc2 and 3.2P.
Effect of hetero-oligomer formation on cell surface Env
antigenicity
To test whether the presence of cleavage-defective Env
affected MAb binding to cleavage-competent Env on the
surface of Env-transfected cells, a population of 293T cells was. The pseudovirions used were as follows: 3.2P(+) gp140Δct Env (•), 2G12-
N295A/N332A 3.2P(+) gp140Δct Envs co-transfected in a 1:1 proportion (▴);
on (O); or a mixture of cleavage-competent 3.2(+) Env-pseudotyped virions with
nv (◊). The different pseudovirion preparations were incubated for 1 h at 37 °C
d, prior to addition to U87.CD4.CXCR4 cells. The outcome of infection was
culated. Data points represent the mean (±SD) derived from four determinations
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competent and cleavage-defective forms of 3.2P gp140Δct
Env. The binding of MAb 2F5 to this cell population was
determined as a ratio of 2G12 binding, as previously described
(Herrera et al., 2005). To provide a frame of reference, we
mixed, in different proportions, cells that had been transfected
with only cleavage-competent Env or with only cleavage-
defective Env. Consistent with previous studies (Herrera et al.,
2005; Si et al., 2003), MAb 2F5 bound more to the cleavage-
defective Env than to the cleavage-competent protein (Fig. 3).
When the cleavage-defective Env was co-transfected with the
cleavage-competent Env, the binding was increased from the
low level obtained using 2F5 and only cleavage-competent Env.
At 50% cleavage-defective Env (1:1 transfection mixture), 2F5
bound almost at the level observed when only the cleavage-
defective Env was present. The extent to which 2F5 bound in
the presence of the co-transfected, uncleaved Env protein was
greater than was observed when the two cell populations
expressing the two different forms of Env were simply mixed in
the same proportions. Thus, the median MFI ratio for 2F5/2G12Fig. 5. 2G12 does not neutralize pseudoviruses bearing 2G12 knockout 3.2P(+)
neutralization by other Abs. (A) The pseudovirions used were as follows: 3.2P(+) g
2G12-knockout N295A/N332A 3.2P(+) and cleavage-defective 3.2P(−) gp140Δct
knockout N295A/N332A 3.2P(+) gp140Δct Env or cleavage-defective 3.2P(−) gp
transfected in a proportion 1:1 (•); or a mixture of cleavage-competent 3.2P(+)
cleavage-defective 3.2P(−) gp140Δct Env (○). The pseudovirions were incubated
addition to U87.CD4.CXCR4 cells. The outcome of infection was determined after
represent the mean (±SD) derived from four determinations from two independen
without (■) 2G12 MAb at 37 °C, then with b12 (B) or CD4-IgG2 (C) for 45 min a
outcome of infection was determined after 4 days and the percentage neutralization
four determinations from two independent experiments.binding was 0.51 (range: 0.50–0.54, n = 4) vs. 0.40 (range:
0.37–0.41, n = 3), in the two circumstances. The difference is
significant (P = 0.029, one-tailed Mann–Whitney test).
Effect of hetero-oligomer formation on neutralization
sensitivity
The observation that cleavage-defective Env has a disrupting
effect on Wt Env function led us to conclude that individual
pseudovirions can contain a mixture of functional and
nonfunctional Env complexes. We therefore tested whether
the presence of these nonfunctional Envs on the surface of
infectious virions would affect the neutralization of Env-
pseudotyped virions by MAbs.
Env-pseudotypedvirions bearing eitherWt3.2P(+) gp140Δct
Env or a 1:1 mixture of Wt and cleavage-defective Env proteins
had similar sensitivities to neutralization by 2G12, CD4-IgG2,
b12 or 2F5 (Fig. 4). Neutralization assays were performed
using unpurified transfection supernatants normalized for
luciferase output, though this similarity was evident whethergp140Δct and cleavage-defective 3.2(−) gp140Δct Envs, or enhance their
p140Δct Env (O); 2G12-knockout N295A/N332A 3.2P(+) gp140Δct Env (■);
Envs in a 1:1 proportion (▴); a 1:1 mixture of pseudovirions bearing 2G12-
140Δct Env (▵); 3.2P(+) and cleavage-defective 3.2P(−) gp140Δct Env co-
Env-pseudotyped viruses with an equal proportion of pseudovirions bearing
for 1 h at 37 °C with 2G12 MAb at the concentrations indicated, prior to
4 days and the percentage neutralization by the Ab was calculated. Data points
t experiments. (B, C) Pseudoviruses were incubated for 30 min with (□) or
t the indicated concentrations prior to addition to U87.CD4.CXCR4 cells. The
by each Ab was calculated. Data points represent the mean (±SD) derived from
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virus was normalized to the p24 content or the infectivity of the
1:1 Env-pseudotyped virus stock, and whether we used un-
purified transfection supernatants or Env-pseudotyped virions
clarified through either a 20% sucrose cushion or an iodixanol
gradient (Herrera et al., 2005) (data not shown). In addition, a
mixture of Wt 3.2P(+) gp140Δct Env-pseudotyped virus with
cleavage-defective Env-pseudotyped virus generated essential-
ly the same neutralization profile as the Wt 3.2P(+) gp140Δct
Env-pseudotyped virus stock (Fig. 4). We confirmed that the
N295A/N332A 3.2P(+) gp140Δct Env-pseudotyped virus re-
sisted neutralization by MAb 2G12, but was similar to Wt
3.2P(+) gp140Δct Env-pseudotyped virus in its sensitivity to
neutralization by CD4-IgG2, b12 or 2F5 (Fig. 4). The phe-
notypically mixed virus bearing both 3.2P(+) gp140Δct Env
and N295A/N332A 3.2P(+) gp140Δct Env (1:1) had an in-
termediate sensitivity to 2G12 neutralization (Fig. 4A). There
was a minor, but nevertheless consistent, resistance of pseu-
doviruses bearing the Wt 3.2P(+) gp140Δct and cleavage-
defective Env to neutralization by CD4-IgG2, compared to the
Wt or the admixed Env-pseudotyped virus stocks (Fig. 4B).
Overall, we conclude that the presence of cleavage-defective,
nonfunctional Env proteins does not affect the ability of neutral-
izing agents to block virus infectivity.
We also wished to determine whether antibody binding to
cleavage-defective, nonfunctional Env would interfere with
the function of cleaved Env. The absence of such an effect
would further strengthen the evidence that mixed trimers are
inert. However, any such inhibition could also be explained
by steric effects on adjacent, fusion-competent trimers. In
this experiment, we co-expressed the 2G12-nonantigenic, but
otherwise fully functional, N295A/N332A 3.2P(+) gp140Δct
Env with the 3.2P(−)gp140Δct Env. Env-pseudotyped
virions bearing these Envs (at a proportion of 1:1) retained
∼10% of the infectivity of the Wt 3.2P(+) gp140Δct Env-
pseudotyped virus, though the input infectious dose in the
neutralization experiments was normalized to be the same
for the two viruses. These virions containing a mixture of
3.2P(−)gp140Δct and N295A/N332A 3.2P(+) gp140Δct or
3.2P(+) gp140Δct were used to investigate the neutralizing
effect of the binding of 2G12 only to inert, uncleaved Env.
2G12 not only had no neutralizing activity under these
conditions, but it also actually caused a concentration-
dependent enhancement of infectivity by up to 50%
(Fig. 5A).
We also tested whether any steric effects of 2G12-binding to
nonfunctional Env would potentiate the neutralization by
ligands binding to the CD4-binding site on gp120. Pseudotyped
viruses bearing the N295A/N332A 3.2P(+) gp140Δct and
cleavage-knockout Envs were therefore incubated with a
saturating amount of 2G12, before addition of b12 or CD4-
IgG2. The presence of 2G12 had no effect on neutralization by
b12 or CD4-IgG2 (Figs. 5B, C). This again suggests that only
binding to cleavage-competent homotrimers is relevant to
neutralization; the nonfunctional Env spikes (which retain the
ability to bind 2G12) may not be sufficiently proximal to the
functional Env spikes (which cannot bind 2G12) to enhancethe neutralizing effect of blocking the CD4-binding site on
the latter.
Discussion
Dominant-negative inhibition of infectivity by uncleaved Env
proteins
The infectivity profiles of Env-pseudotyped viruses
generated in the presence of differing proportions of
cleavage-defective and cleavage-competent Env are consistent
with the proposal that only Wt homotrimers are functional.
Models that assume such uniformity at the trimer level and
heterogeneity of thresholds at the virion level fit our data very
closely. Recently, stoichiometric studies on antibody neutral-
ization and the effects of defective Env on virion infectivity,
using modeling methods different from ours, also concluded
that only homotrimers bearing, respectively, nonantigenic or
nondefective subunits are functional (Yang et al., 2005a,
2005b). It was also concluded that an HIV-1 virion requires
only a single functional trimer in order to infect a cell (Yang
et al., 2005a, 2005b). The model used by Yang et al. (2005a,
2005b) is similar to our Model 1, with a = 1. Such a model
does not fit our data for the JR-FL strain. If we assume that
there are 9 functional trimers per virion, our analysis suggests
that a minimum of 4–5 functional trimers is required for
infectivity. If the real number of functional trimers per virion
is higher than this, and mid-range thresholds are more gradual
than we modeled, it is still possible to derive similar curves.
More generally, our experimental data can be shown to be
compatible with the hypothesis that each virion has several
functional trimers, with a substantial proportion of them being
required for infectivity, as we will show in detail elsewhere
(Klasse, in preparation).
Overall, there may be a spectrum of infectiousness among
virions within any given population. The infectious capacity of
pseudovirions would then depend on the number of functional
trimers that are incorporated and retained in an active
conformation. This conclusion is, however, seemingly contra-
dicted by the negligible impact that uncleaved, yet theoretically
cleavable, Env proteins appear to have on pseudovirus
infectivity (Herrera et al., 2005). The paradox is most simply
explained, however, by the all-or-none processing of Env on a
trimer during the late stages of Env synthesis. When a trimer is
formed from cleavable Env proteins, the entire trimer must be
processed by the host cell endoproteases as a single entity;
either all three subunits are cleaved, or none of them is. This
presumably occurs because the entire trimer slips past the
processing proteases, something that may be particularly likely
to happen when Env proteins are expressed at unusually high
levels, or in cell types with a low complement of processing
enzymes. We can reasonably presume that trimers comprising
three uncleaved, but cleavable, Env proteins behave like those
containing three cleavage-defective, mutant proteins (Binley et
al., 2000).
In contrast, another situation arises with the cleavage-
defective Env proteins. A heterotrimer containing one or two of
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cleavage-defective subunits would not be processed at the time
when the cleavage-competent subunits are successfully cleaved.
If, as we believe, the presence of a single uncleaved subunit in
the trimer impairs the functionality of the entire trimer, then
these heterotrimers are fusion-defective when they make their
way onto the cell and/or pseudovirion surface. Thus, the mutant
subunits behave in a dominant-negative manner to impair the
activity of the Wt ones.
We detected more binding by the MAb 2F5 to cells that were
co-expressing Wt and cleavage-defective 3.2P Env than to a
mixture of cells expressing either (Fig. 3). One explanation is
that heterotrimers are present on the surface of the co-
transfected cells, and that the uncleaved Env proteins have a
dominant, enhancing effect on the overall binding of MAb 2F5
to the heterotrimer. This would, once more, imply that the
biophysical properties of cleaved and uncleaved forms of Env
are significantly different (Herrera et al., 2005; Si et al., 2003).
Alternatively, it could mean that fewer than three 2F5 antibodies
can bind per trimer and that 2F5 has a higher affinity for the
uncleaved Env chains, without any allosteric effects on the
neighboring chains in the trimers. The formation of hetero-
trimers would thus spread the number of high-affinity potential
binding sites to a greater number of trimers.
We also found that only antibodies able to bind to
functional Env subunits can neutralize pseudoviruses. This
provides independent evidence that mixed trimers, containing
both functional and functionally blocked subunits, are inert.
While certain gp120 or gp41 mutations can compensate for
each other and are compatible with the function of fully
cleaved trimers (Salzwedel and Berger, 2000), all three
gp120–gp41 components must be cleaved for the trimer to
be functional. Since antibodies to the fusion-defective
moieties did not reduce infection, and did not enhance
neutralization by agents directed to the CD4-binding site on
gp120, antibody binding to one trimer seems not to sterically
affect the function of neighboring trimers. This lack of inter-
trimer effects by the binding of IgG molecules agrees with the
finding that whereas a tetravalent CD4-IgG2 construct can
bridge the typical distance between two trimers, a simple
CD4-IgG hybrid cannot (Zhu et al., 2001).
We found that the MAb 2G12 weakly enhanced the
infectivity of pseudovirons with mixed 2G12-antigenic
cleavage-defective and cleavage-competent 2G12 knockout
Env in a concentration-dependent manner. An explanation for
this might be that 2G12 binding to uncleaved Env proteins
blocks abortive interactions between these proteins and cell
surface receptors, which thereby increases the availability of
receptors in the fusion process. The lack of any neutralizing
effect indicates that nonfusogenic Env does not enhance virus
infectivity by providing ancillary points of attachment to the
cell surface. Furthermore, if mixed trimers did retain some
fusion function, ligation of their uncleaved moiety would be
likely to block the function of the other moieties sterically;
this was not observed.
In conclusion, several lines of evidence support the
hypothesis that an Env trimer requires all three subunits tobe cleaved in order to successfully mediate entry. Further-
more, the neutralization of a virion by an antibody is a
consequence of the direct interference of the fusion function
of a critical proportion of the virion's complement of Env
trimers.
Materials and methods
Reagents and plasmids
MAb b12 was a gift from Dennis Burton (Scripps Research
Institute, La Jolla, CA) (Burton et al., 1994). MAbs 2F5 and
2G12 were provided by Herman Katinger (Polymun Scientific
Inc, Vienna, Austria) (Muster et al., 1993). The CD4-IgG2
molecule (PRO 542) was a gift from Bill Olson (Progenics Inc.,
Tarrytown, NY) (Trkola et al., 1995). Antibodies D7320 and
D7324 are anti-p24 and anti-gp120 sheep polyclonal antibodies,
respectively (Cliniqa Corp., Fallbrook, CA).
Env genes encoding full-length gp160 proteins from HIV-1
JR-FL and HXBc2 were cloned using PCR from source (Trkola
et al., 1998) templates into the mammalian expression vector
pCI (Promega, Madison, WI). Cleavage site mutants were made
by altering the primary cleavage site REKR (residues 508–511
of the gp120 C5 domain) to IEGR (R508I/K510G) by site-
directed mutagenesis (Stratagene, La Jolla, CA) (Herrera et al.,
2005). The pNL4/3.Luc plasmid (also known as pNL-Luc-
E−R+) was obtained from Nathaniel Landau (Connor et al.,
1996).
The neutralization-resistant variant 3.2P of the HXBc2 virus
has been described previously (Cayabyab et al., 1999), as has
the functional Wt 3.2P(+) gp140 (Δct) Env clone (Si et al.,
2001). The 3.2P(−) variant of this Env protein has the primary
cleavage site between gp120 and gp41 altered to SEKS, to
prevent cleavage by furin-family endoproteases (Si et al., 2003).
Both the 3.2P(+) and the 3.2P(−)gp140 (Δct) Env clones were
generous gifts from Drs. J Sodroski and Z Si (Dana-Farber
Cancer Institute, Boston, MA). An alternative modification to
the primary cleavage site, identical to that introduced into JR-
FL Env (REKR to IEGR), was made by site-directed
mutagenesis. When both primary cleavage site mutants, SEKS
and IEGR, were compared directly, we could find no significant
qualitative differences between them; we therefore refer to them
both as cleavage-defective Env(−) (Herrera et al., 2005).
Recombinant reporter viruses expressing 3.2P(+) gp140Δct
Env were generated by co-transfection with Env plasmid,
packaging plasmid (pCMVΔP1ΔenvpA) and an HIV-1 vector
plasmid expressing firefly luciferase (pLuc), as described
previously (Si et al., 2001).
The 2G12 binding site was eliminated in 3.2P(+) gp140Δct
Env by alanine substitutions at positions N295 and N332
(N295A/N332A 3.2P(+) gp140Δct) using site-directed muta-
genesis as previously described (Scanlan et al., 2002).
Cell lines and conditions for transfections
All cell cultures were maintained at 37 °C in an atmosphere
containing 5% CO2. Human epithelial kidney (HEK) 293T cells
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Grand Island, NY) containing 10% fetal calf serum, 2 mM L-
glutamine, antibiotics (100 U/ml penicillin, 100 μg/ml strepto-
mycin) and 0.5 mg/ml of the neomycin analog G-418. U87.
CD4.CCR5 and U87.CD4.CXCR4 cells (provided by Dan
Littman) were cultured in the same conditions described for
HEK 293T cells but with 0.3 mg/ml of G-418 and 0.5 μg/ml of
puromycin.
293T cells were transiently transfected using the calcium
phosphate precipitation method (Profection mammalian trans-
fection system-calcium phosphate; Promega). Briefly, plasmids
were co-transfected into 293T cells in a 6-well plate containing
3 ml of culture medium without antibiotics. The cells were
washed 15 h later, and re-fed with 3 ml of the same culture
medium.
Purification of HIV-1 by iodixanol gradient centrifugation
Pseudoviruses were generated by transient transfection of
293T cells, then enriched by velocity gradient centrifugation on
6–18% iodixanol gradients (Optiprep; Axis-Shield, Oslo,
Norway) (Dettenhofer and Yu, 1999); gradient fractions were
assayed for p24 content and infectivity as described (Herrera et
al., 2005).
For the immunoprecipitation of mixed oligomers, fractions
corresponding to the peak of infectious particles were incubated
on ice with TSA buffer (150 mM NaCl, 10 mM Tris, pH 8)
containing 1% Nonidet-P40 (NP40), and 1× “Complete
Cocktail Protease Inhibitors” (Roche Diagnostic GmbH,
Mannheim, Germany), to release pseudovirion-associated Env
trimers, prior to incubation with 2G12 MAb overnight at 4 °C.
The MAb-Env complexes were precipitated with protein G
agarose beads (Pierce Biotechnology, Rockford, IL) and
washed several times with TSA buffer before being lysed in
polyacrylamide gel electrophoresis (PAGE) loading buffer
(supplemented with 2% sodium dodecyl sulfate (SDS) and
100 mM dithiothreitol (DTT)). SDS-PAGE analysis was carried
out under reducing conditions, with MAb 2F5 used for gp41
detection (Herrera et al., 2005).
Neutralization assays
The pseudoviruses were mixed with serially diluted MAb for
1 h at 37 °C, then added to U87.CD4.CCR5 or U87.CD4.
CXCR4 cells. The luciferase content of cell lysates was
measured 3–4 days post-infection, as described elsewhere
(Herrera et al., 2005).
Virus and gp120 capture ELISA
Virus capture assays were performed as described previously
(Herrera et al., 2005; Poignard et al., 2003).
CD4-IgG2 and MAb 2G12 binding to 3.2P(+) gp140Δct and
N295A/N332A 3.2P(+) gp140Δct Env derived from NP40-
lysed virions was determined using a capture ELISA in which
gp120 was immobilized with the anti-gp120 antibody D7324
(Trkola et al., 1995).Immunostaining assay
Transfected 293T cells (2 × 106 per sample) were washed
with PBS and incubated for 1 h at room temperature with an
anti-Env MAb. The binding of MAb was detected by flow
cytometry as previously described (Herrera et al., 2003).
Modeling
Trimer-level modeling and Model 1
The relative frequency of theWt Env monomers is defined as
p. It is considered to be proportional to the relative DNA content
used for transfection.
The minimal number of mutant subunits that inactivates a
trimer is designated as N. For example, N = 1, a dominant-
negative effect of mutant Env at the trimer level, means that the
functional fraction of trimers = p3.
Another possibility is that the incorporation of uncleaved
Env causes a proportionally incremental inactivation of the
trimer by one third. Other special cases may be biologically
implausible, e.g., N = 2 or N = 3, which mean that some
heterotimers have exactly the same functionality as Wt
homotrimers. The infectivity data obtained with the mixed
trimers are not extensive or precise enough to allow a
simultaneous differentiation between all these possibilities. To
simplify our modeling, we therefore consider only the spectrum
of possibilities between the two extreme cases: N = 1 (i.e., a
dominant-negative effect of mutant Env at the trimer level), and
proportionally incremental inactivation, which contains the
other possibilities since mathematically it corresponds to the
mean of the functions for N = [1,2,3] (Klasse, in preparation). If
the infectivity of each virion was exactly proportional to its
number of functional trimers (each within the spectrum from
N = 1 to incremental inactivation), then the relative infectivity, I,
would be:
I ¼ ap3 þ ð1 aÞp:
The parameter a is constrained (0 < a < 1) and is fit by
nonlinear regression. This is Model 1 in Table 1.Virion-level modeling and Model Group 2
We also developed a group of models incorporating the
condition N = 1 as described above, but which allowed for
nonlinear effects of trimer functionality at the virion level.
These models postulate that a certain proportion of the trimers
on each virion may be critical for infectivity (Klasse and Moore,
1996). To model any such threshold effects, one has to make
assumptions about the total number of functional trimers on
virions. Recent biochemical studies of Gag and Env contents in
HIV-1 and SIV preparations have estimated that there are 7–16
trimers per virion (Chertova et al., 2002; Yuste et al., 2004), but
that range may need to be corrected upwards because of
improvements in the determination of the number of Gag
molecules per virion (Briggs et al., 2004). Electron-microscopic
studies have suggested that the full complement of trimers per
HIV-1 particle is 72 (Grewe et al., 1990), but a more recent
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(Zhu et al., 2003). It is possible that infectious virions have
significantly above-average numbers of Env trimers. However,
the number of functional trimers is likely to constantly decline
over time, and only the minority of the total trimers that is
functional is relevant to modeling. As a compromise between
these considerations, we assume that there are 9 trimers per
virion and let S be the threshold number of trimers that must be
inactivated for the virion to lose its infectivity. Then with q
being the proportion of functional trimers, we get a relative
infectivity for each of the nine thresholds (Klasse, in
preparation):
IS ¼
X9
r ¼ ð9  S þ 1Þ
9Crq
rð1 qÞ9r:
These thresholds can then be blended into average soft or
composite thresholds by letting the coefficients c1,…, c9 give
them different weights:
I ¼ ðc1IS ¼ 1 þ c2IS ¼ 2 þ c3IS ¼ 3 þ cvIS ¼ 4 þ c5IS ¼ 5
þ c6IS ¼ 6 þ c7IS ¼ 7 þ c8IS ¼ 8 þ c9IS ¼ 9Þ
=ðc1 þ c2 þ c3 þ c4 þ c5 þ c6 þ c7 þ c8 þ c9Þ:
We developed a library of different thresholds by setting cx to
0 or to the parameter value b raised to the 0th to 9th (arbitrary)
degree. This is not an exhaustive set of functions but it
represents a great variety of threshold combinations. Candidate
functions that approximated the infectivity data for the three
viral strains were then fit by nonlinear regression to optimize the
value for the parameter b, which was constrained to >0. This
modeling thus tests the hypothesis that there are critical
proportions of trimers per virion. If, in contrast, virion
infectivity was simply proportional to total trimer functionality,
there would be a convergence to universal coefficients b0 (=1)
among the candidate functions or b = 1 in the nonlinear
regression, and Model Group 2 would then coalesce with Model
1, a = 1.
Nonlinear regression was performed with initial values
a = 0.5 and b = 2. The relative merits of Model 1 and of the
individually fit versions of Model Group 2 were evaluated by
Akaike's information criterion (AIC) in Prism (Graphpad). AIC
was used because the models are not nested in a simple manner,
although extreme special cases that fall under the respective
models converge. The comparisons were performed such that
the higher the Akaike score, the greater was the preference for
Model Group 2. The score was also translated into %
probability of correctness.
Outside of the modeling, one-tailed Mann–Whitney test
(Prism, Graphpad) was performed to evaluate the significance
of differences in infectivities and Ab binding.
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